ResearcherFirst Affiliated Hospital of Guangdong Pharmaceutical UniversityActive in the last 2 years
Qing Xi
Matched on ORCID iD 0000-0001-8011-5219; OpenAlex author ID A5048502872. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Piperine Inhibits the Immune Checkpoint CD47 to Enhance Immunity Against Pancreatic Cancer. Co-author DOI 10.1002/ptr.70110↗
- Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects. Co-author DOI 10.1016/j.mam.2025.101368↗
- miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.intimp.2021.107822↗
- Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity. Co-author DOI 10.1136/jitc-2019-000253↗
- miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2020.00890↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rongxin Zhang · 5 shared papers, 2020–2026 · strength 0.86
- Paper Piperine Inhibits the Immune Checkpoint CD47 to Enhance Immunity Against Pancreatic Cancer. DOI 10.1002/ptr.70110↗
- Paper Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects. DOI 10.1016/j.mam.2025.101368↗
- Paper miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. DOI 10.1016/j.intimp.2021.107822↗
- Xue He · 1 shared paper, 2026 · strength 0.30
- Jinyi Zhang · 1 shared paper, 2025 · strength 0.25
- Li Yan · 2 shared papers, 2020–2021 · strength 0.23
- Chengzhi Wang · 2 shared papers, 2020–2021 · strength 0.21
- Paper miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. DOI 10.1016/j.intimp.2021.107822↗
- Paper Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance a… DOI 10.1136/jitc-2019-000253↗
- Ying Chen · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.